EVALUATION OF THE EFFECTIVENESS OF THROMBOLYTIC THERAPY IN MYOCARDIAL INFARCTION IN THE CONDITIONS OF THE SAMARKAND BRANCH OF RSCEMC

Authors

  • Fatulloyeva D.S Fatulloeva Dilnoza Sayfulloeva –resident of master`s degree in Cardiology of the Samarkand State medical institute
  • Tashkenbaeva E.N Tashkenbaeva Eleanora Hegmatovna-doctor of medical science, head of department of internal diseases internal diseases ? 2 of Samarkand State medical Institute
  • Abdieva G.A Abdieva Gulnora Alievna-assistant of the Department of internal diseases internal diseases ? 2 of Samarkand State medical Institute
  • Madjidova G.T Madjidova Gulbaxop Talibovna- assistant of the Department of internal diseases internal diseases ? 2 of Samarkand State medical Institute
  • Xaitov I.I Xaitov Isomiddin Ikromovich- resident of master`s degree in Cardiology of the Samarkand State medical institute
  • Murodqobilov O.A Murodqobilov Ozod Anvarovich –resident of master`s degree in Cardiology of the Samarkand State medical institute

Keywords:

Cardiology, myocardial infarction, ischemic stroke, thrombosis, hemoderucia, coronary angioplasty, stenting, hemorrhage

Abstract

The effectiveness of TLT depends on the thrombolytic drug used, which in its main characteristics should be, first of all, safe, with the absence or maximum low risk of hemorrhagic complications, including - intracranial bleeding, the absence of side and allergic reactions, effective with verified coronary reperfusion in the highest percentage of cases, convenient in the application of pain-injected, which contributes to the early onset of repertures of the myocard, and of course, economically available to the population

Downloads

Published

2021-01-18

Issue

Section

Articles

How to Cite

EVALUATION OF THE EFFECTIVENESS OF THROMBOLYTIC THERAPY IN MYOCARDIAL INFARCTION IN THE CONDITIONS OF THE SAMARKAND BRANCH OF RSCEMC. (2021). Euro-Asia Conferences, 1(1), 177-182. https://papers.euroasiaconference.com/index.php/eac/article/view/52